• Users Online: 429
  • Print this page
  • Email this page
Year : 2015  |  Volume : 9  |  Issue : 4  |  Page : 155-158

BK virus-related thrombotic microangiopathy in a kidney transplant recipient

Department of Nephrology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara, Turkey

Correspondence Address:
Ebru Gok Oguz
Department of Nephrology, Diskapi Yildirim Beyazit Education and Research Hospital, Ankara
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.1016/j.ijt.2015.10.008

Rights and Permissions

Thrombotic microangiopathy (TMA) is a clinical condition resulting from severe endothelial damage and leading to microangiopathic hemolytic anemia, consumptive thrombocytopenia, and ischemia of distal organs. TMA does not only develop in the native kidney but also appears as a recurrent or de novo condition in the transplanted kidney. Etiology of de novo TMA includes renal ischemia, antibody-mediated rejection, malignancies, viral infections (CMV, parvovirus B19, BK polyomavirus, and HHV-6), antiphospholipid antibodies, anticardiolipin antibodies developing in HCV-positive patients, and medications (calcineurin inhibitors, m-TOR inhibitors, and antiviral medications). Early diagnosis and treatment of TMA can be lifesaving. In this report, we present our experiences of successful treatment of a renal transplant case of TMA due to BK virus, not a frequent cause of TMA. The clinical picture of TMA caused by endothelial damage through cytopathic effects of viral antigens was evaluated in the light of the relevant literature.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded87    
    Comments [Add]    

Recommend this journal